Recent advances in the development of mutant-selective EGFR inhibitors for non-small cell lung cancer patients with EGFR-TKI resistance

Transl Lung Cancer Res. 2014 Dec;3(6):368-9. doi: 10.3978/j.issn.2218-6751.2014.09.07.
No abstract available